Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer. (Q39354188)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 June 2017
edit
Language Label Description Also known as
English
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
scientific article published on 6 June 2017

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit